Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.
作者信息
Shen Erica, Johnson Margaret O, Lee Jessica W, Lipp Eric S, Randazzo Dina M, Desjardins Annick, McLendon Roger E, Friedman Henry S, Ashley David M, Kirkpatrick John P, Peters Katherine B, Walsh Kyle M
机构信息
Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
The Preston Robert Tisch Brain Tumor Center, Duke School of Medicine, Durham, North Carolina.
出版信息
Neurooncol Adv. 2019 Dec 20;1(1):vdz036. doi: 10.1093/noajnl/vdz036. eCollection 2019 May-Dec.
Abstract
摘要
相似文献
1
Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.老年队列中异柠檬酸脱氢酶野生型胶质母细胞瘤患者生存列线图的性能
Neurooncol Adv. 2019 Dec 20;1(1):vdz036. doi: 10.1093/noajnl/vdz036. eCollection 2019 May-Dec.
2
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.一种经独立验证的用于异柠檬酸脱氢酶野生型胶质母细胞瘤患者生存情况的列线图。
Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.
3
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.最大程度切除增强和非增强肿瘤与新诊断胶质母细胞瘤患者分子亚群生存的关联。
JAMA Oncol. 2020 Apr 1;6(4):495-503. doi: 10.1001/jamaoncol.2019.6143.
4
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.初次手术切除和从初次诊断到复发的时间间隔是 IDH 野生型复发性胶质母细胞瘤经手术切除后的独立预后因素。
Clin Neurol Neurosurg. 2020 Sep;196:106006. doi: 10.1016/j.clineuro.2020.106006. Epub 2020 Jun 8.
5
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent wild-type glioblastoma.激光间质热疗（LITT）治疗新诊断和复发性野生型胶质母细胞瘤的疗效
Neurooncol Adv. 2022 Apr 6;4(1):vdac040. doi: 10.1093/noajnl/vdac040. eCollection 2022 Jan-Dec.
6
Gyriform infiltration as imaging biomarker for molecular glioblastomas.脑回样浸润作为分子胶质母细胞瘤的影像生物标志物。
J Neurooncol. 2022 May;157(3):511-521. doi: 10.1007/s11060-022-03995-9. Epub 2022 Apr 1.
7
Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.IDH1 单核苷酸多态性 rs11554137 在胶质母细胞瘤中的临床预后价值。
J Neurooncol. 2018 Jun;138(2):307-313. doi: 10.1007/s11060-018-2796-6. Epub 2018 Feb 8.
8
neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival.neoDL：一种基于新型抗原内在特征的深度学习模型，可识别 IDH 野生型胶质母细胞瘤患者，此类患者的生存时间最长。
BMC Bioinformatics. 2021 Jul 23;22(1):382. doi: 10.1186/s12859-021-04301-6.
9
Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.IDH 野生型胶质母细胞瘤中 Ki-67 指数过表达是否预示无进展生存期更短？一项临床和分子分析研究。
Clin Neurol Neurosurg. 2020 Nov;198:106126. doi: 10.1016/j.clineuro.2020.106126. Epub 2020 Aug 3.
10
Predictive value of MGMT promoter methylation on the survival of TMZ treated -mutant glioblastoma.MGMT 启动子甲基化对替莫唑胺治疗的突变型胶质母细胞瘤患者生存的预测价值。
Cancer Biol Med. 2021 Feb 15;18(1):272-282. doi: 10.20892/j.issn.2095-3941.2020.0179.
引用本文的文献
1
Prognostic nomogram models for predicting survival probability in elderly glioblastoma patients.用于预测老年胶质母细胞瘤患者生存概率的预后列线图模型。
J Cancer Res Clin Oncol. 2023 Nov;149(15):14145-14157. doi: 10.1007/s00432-023-05232-w. Epub 2023 Aug 8.
2
Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma.IDH野生型胶质母细胞瘤老年患者的预后分析与列线图构建
Heliyon. 2023 Jul 17;9(7):e18310. doi: 10.1016/j.heliyon.2023.e18310. eCollection 2023 Jul.
3
Optimizing management of the elderly patient with glioblastoma: Survival prediction online tool based on BC Cancer Registry real-world data.优化胶质母细胞瘤老年患者的管理：基于卑诗省癌症登记处真实世界数据的生存预测在线工具。
Neurooncol Adv. 2022 Apr 13;4(1):vdac052. doi: 10.1093/noajnl/vdac052. eCollection 2022 Jan-Dec.
4
A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.手术队列中初诊成人丘脑胶质瘤患者的预后列线图
Neuro Oncol. 2021 Feb 25;23(2):337-338. doi: 10.1093/neuonc/noaa268.
本文引用的文献
1
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.一种经独立验证的用于异柠檬酸脱氢酶野生型胶质母细胞瘤患者生存情况的列线图。
Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.
2
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.美国 2000 年至 2014 年按种族或族裔划分的成人脑胶质瘤发病率和生存率。
JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.
3
Management of glioblastoma in elderly patients.老年胶质母细胞瘤的治疗管理。
J Neurol Sci. 2017 Sep 15;380:250-255. doi: 10.1016/j.jns.2017.07.048. Epub 2017 Aug 1.
4
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.老年胶质母细胞瘤：积极和现代治疗方法对生存的影响。
J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.
5
Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma.老年原发性恶性星形细胞瘤患者的护理模式与预后
J Neurosurg. 2008 Apr;108(4):642-8. doi: 10.3171/JNS/2008/108/4/0642.
6
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.放疗联合同步及辅助替莫唑胺治疗胶质母细胞瘤
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
Zotero 插件